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Error in Charing Cross Venous Ulcer Questionnaire
(CXVUQ)
We have encountered an unexpected problem with the Char-
ing Cross Venous Ulcer Questionnaire (CXVUQ), an ulcer-
specific quality-of-life instrument previously reported in this jour-
nal.1 When designing the Honey as Adjuvant Leg ulcer Therapy
(HALT) Trial (ISRCTN06161544), the CXVUQ appeared to be
a promising tool that would complement the more generic Short
Form-36 (SF-36).
When we analyzed the data, however, two domains (cosmesis
and emotional status) scored considerably higher than the other
domains (Table), which seemed incongruent with the scoring of
CXVUQ. Low scores on the CXVUQ indicate better quality-of-
life outcomes. We therefore investigated the scores of all those
participants with healed and unhealed ulcers at end point. The
CXVUQ should have discriminated between those that did heal
and those that did not, irrespective of treatment. Participants with
healed ulcers should have scored lower (ie, better) than those with
unhealed ulcers at end point. However, the opposite was true for
cosmesis and emotional status.
This problem seems to have been created by an error in the
original publication. Questions three and seven were incorrectly
scaled and thus the best answers score highest instead of lowest.
When we recoded the data so that the best answers gave the lowest
scores, the data were more congruent and participants with healed
ulcers did indeed score lower than those with unhealed ulcers.
Another research group using the CXVUQ has independently
arrived at the same solution (Irene Wong and David Thompson,
personal communication),2 and we have since been able to confirm
the error from a second publication by the instrument’s authors.3
This publication is not listed inMedline or CINAHL, and will only
come to user’s attention if they search EMBASE or SCOPUS.
The CXVUQ is a disease-specific instrument that has excellent
potential for use in clinical trials. It appears to have discriminant
characteristics,4 unlike the Hyland scale.5 However, future users
should be aware of the problem we have outlined and its solution.
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Table. Mean domain scores for healed and unhealed cohorts using uncorrected and corrected variables
Domain
Uncorrected results* Corrected results*
Healed Unhealed Healed Unhealed
Social interaction 25.7  11.1 37.6  16.1 24.9  12.2 38.3  17.4
Domestic activities 24.9  11.6 33.9  18.0 23.8  12.9 34.9  19.8
Cosmesis 83.6  11.5 72.7  14.8 30.8  14.8 44.4  18.5
Emotional status 78.2  15.5 65.4  18.7 34.0  17.9 49.6  21.8
*Data presented as mean  standard deviation.
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